RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Sihuan Pharmaceutical Holdings Group Stock

Sihuan Pharmaceutical Holdings Group Stocks 2024

Sihuan Pharmaceutical Holdings Group Stocks

9.3 B

Ticker

460.HK

ISIN

BMG8162K1137

WKN

A1C72G

In 2024, Sihuan Pharmaceutical Holdings Group had 9.3 B outstanding stocks, a 0% change from the 9.3 B stocks in the previous year.

The Sihuan Pharmaceutical Holdings Group Stocks history

YEARNUMBER OF STOCKS (undefined CNY)
2026e9.3
2025e9.3
2024e9.3
20239.3
20229.33
20219.48
20209.47
20199.47
20189.47
20179.48
201610.14
201510.36
201410.36
201310.35
201210.35
201110.36
20108.01
20097.5
20080.94
20070.9
20060.94
20050.94
20040.75

Sihuan Pharmaceutical Holdings Group shares outstanding

The number of shares was Sihuan Pharmaceutical Holdings Group in 2023 — This indicates how many shares 9.297 B is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Sihuan Pharmaceutical Holdings Group earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Sihuan Pharmaceutical Holdings Group's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Sihuan Pharmaceutical Holdings Group’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Sihuan Pharmaceutical Holdings Group's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Sihuan Pharmaceutical Holdings Group Aktienanalyse

What does Sihuan Pharmaceutical Holdings Group do?

Sihuan Pharmaceutical Holdings Group Ltd is a leading company in the Chinese pharmaceutical industry that focuses on research, development, production, and marketing of drugs, especially for the treatment of cardiovascular diseases and central nervous system diseases. The company was founded in 2001 and has become one of the largest and most successful companies in the Chinese pharmaceutical industry. It is listed on the stock exchange and has its headquarters in Beijing, China. Sihuan Pharmaceutical's business model is based on a combined strategy of researching and developing new drugs tailored to the Chinese market, as well as licensing and distributing existing drugs from both domestic and international sources. The company is divided into various business divisions to maximize its core competencies and maintain growth. The cardiovascular division is one of the most important divisions, producing and distributing cardiovascular drugs used to treat conditions such as hypertension, heart failure, arrhythmias, and other cardiovascular diseases. The central nervous system division is another important division, producing and distributing drugs to treat neurological disorders such as depression, schizophrenia, and epilepsy. In addition, the company also has products in the areas of antibiotics, antivirals, and gastroenterology. Sihuan Pharmaceutical's research and development department focuses on the discovery and development of new active substances, as well as improving existing drugs. The company collaborates with leading universities and research institutions in China and globally to develop innovative approaches in pharmacy. Sihuan Pharmaceutical has also established a strong presence in the Chinese market, building an extensive distribution network throughout China and working closely with other key players in the industry to strengthen its market position. In summary, Sihuan Pharmaceutical Holdings Group Ltd is a significant player in the Chinese pharmaceutical industry, specializing in the research, development, production, and marketing of drugs for the treatment of cardiovascular diseases and central nervous system diseases. The company is divided into multiple business divisions and has a strong presence in the Chinese market. With its strong research and development department, Sihuan Pharmaceutical is committed to improving the health and well-being of millions of people worldwide. Sihuan Pharmaceutical Holdings Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating Sihuan Pharmaceutical Holdings Group's Shares Outstanding

Sihuan Pharmaceutical Holdings Group's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in Sihuan Pharmaceutical Holdings Group’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding Sihuan Pharmaceutical Holdings Group’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in Sihuan Pharmaceutical Holdings Group’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about Sihuan Pharmaceutical Holdings Group stock

How many stocks are there of Sihuan Pharmaceutical Holdings Group?

The current number of stocks of Sihuan Pharmaceutical Holdings Group is 9.3 B undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of Sihuan Pharmaceutical Holdings Group are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of Sihuan Pharmaceutical Holdings Group evolved in recent years?

The number of shares of Sihuan Pharmaceutical Holdings Group has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. Sihuan Pharmaceutical Holdings Group as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of Sihuan Pharmaceutical Holdings Group?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does Sihuan Pharmaceutical Holdings Group pay?

Over the past 12 months, Sihuan Pharmaceutical Holdings Group paid a dividend of 0.07 CNY . This corresponds to a dividend yield of about 11.4 %. For the coming 12 months, Sihuan Pharmaceutical Holdings Group is expected to pay a dividend of 0.05 CNY.

What is the dividend yield of Sihuan Pharmaceutical Holdings Group?

The current dividend yield of Sihuan Pharmaceutical Holdings Group is 11.4 %.

When does Sihuan Pharmaceutical Holdings Group pay dividends?

Sihuan Pharmaceutical Holdings Group pays a quarterly dividend. This is distributed in the months of October, July, October, November.

How secure is the dividend of Sihuan Pharmaceutical Holdings Group?

Sihuan Pharmaceutical Holdings Group paid dividends every year for the past 16 years.

What is the dividend of Sihuan Pharmaceutical Holdings Group?

For the upcoming 12 months, dividends amounting to 0.05 CNY are expected. This corresponds to a dividend yield of 8.19 %.

In which sector is Sihuan Pharmaceutical Holdings Group located?

Sihuan Pharmaceutical Holdings Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Sihuan Pharmaceutical Holdings Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Sihuan Pharmaceutical Holdings Group from 10/10/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/2/2024.

When did Sihuan Pharmaceutical Holdings Group pay the last dividend?

The last dividend was paid out on 10/10/2024.

What was the dividend of Sihuan Pharmaceutical Holdings Group in the year 2023?

In the year 2023, Sihuan Pharmaceutical Holdings Group distributed 0.052 CNY as dividends.

In which currency does Sihuan Pharmaceutical Holdings Group pay out the dividend?

The dividends of Sihuan Pharmaceutical Holdings Group are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Sihuan Pharmaceutical Holdings Group

Our stock analysis for Sihuan Pharmaceutical Holdings Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sihuan Pharmaceutical Holdings Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.